azomycin has been researched along with Osteosarcoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, GJ; DeNichilo, M; Difelice, C; Evdokiou, A; Findlay, DM; Hay, S; Ingman, W; Liapis, V; Panagopoulos, V; Ponomarev, V; Shoubridge, A; Zannettino, ACW; Zinonos, I; Zysk, A | 1 |
| Atkins, GJ; DeNichilo, M; Evdokiou, A; Findlay, DM; Hay, S; Ingman, W; Labrinidis, A; Liapis, V; Panagopoulos, V; Ponomarev, V; Zannettino, ACW; Zinonos, I | 1 |
| Doege, K; Heine, S; Jelkmann, W; Jensen, I; Metzen, E | 1 |
| Glatstein, E; Makuch, RW; Schwade, JG; Strong, JM | 1 |
| Brustad, T; Rofstad, EK | 1 |
| Abe, M; Hosotani, R; Imamura, M; Manabe, T; Nishimura, Y; Ohshio, G; Shibamoto, Y | 1 |
| Denekamp, J; Flockhart, IR; McNally, NJ; Sheldon, P; Stewart, FA | 1 |
| Smink, T; van Putten, LM | 1 |
| Bleehen, NM; Owen, LN; White, RA; Workman, P | 1 |
| Deys, BF; Stap, J | 1 |
2 trial(s) available for azomycin and Osteosarcoma
| Article | Year |
|---|---|
Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Esophageal Neoplasms; Half-Life; Humans; Injections, Intravenous; Kinetics; Metabolic Clearance Rate; Misonidazole; Nitroimidazoles; Osteosarcoma; Peripheral Nervous System Diseases; Probability | 1982 |
A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Combined Modality Therapy; Female; Humans; Intraoperative Care; Male; Middle Aged; Nitroimidazoles; Osteosarcoma; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Treatment Outcome | 1997 |
8 other study(ies) available for azomycin and Osteosarcoma
| Article | Year |
|---|---|
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Humans; Nitroimidazoles; Osteosarcoma; Phosphoramide Mustards; Prodrugs; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2017 |
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Hypoxia; Female; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Nitroimidazoles; Osteosarcoma; Phosphoramide Mustards; Prodrugs | 2015 |
Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact.
Topics: Active Transport, Cell Nucleus; Cell Line, Tumor; Cell Nucleus; DNA, Mitochondrial; Electron Transport; Fluorescent Dyes; Gene Expression Regulation; Humans; Hypoxia; Microscopy, Fluorescence; Mitochondria; Models, Theoretical; Nitroimidazoles; Osteosarcoma; Oxygen; Oxygen Consumption; Vascular Endothelial Growth Factor A | 2005 |
Radiosensitizing effect of misonidazole in acute and fractionated irradiation of a human osteosarcoma xenograft.
Topics: Adolescent; Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Male; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Osteosarcoma; Transplantation, Heterologous | 1980 |
Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
Topics: Animals; Female; Fibrosarcoma; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Osteosarcoma; Oxygen; Radiation-Sensitizing Agents; Time Factors; Transplantation, Isogeneic | 1978 |
Misonidazole with small dose fractions in an experimental osteosarcoma.
Topics: Animals; Mice; Nitroimidazoles; Osteosarcoma; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sarcoma, Experimental | 1978 |
The penetration of misonidazole into spontaneous canine tumours.
Topics: Adenocarcinoma; Anesthesia, Intravenous; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Dog Diseases; Dogs; Female; Fibrosarcoma; Half-Life; Lymphoma, Non-Hodgkin; Male; Mammary Glands, Animal; Meningioma; Misonidazole; Neoplasms; Nitroimidazoles; Osteosarcoma; Pentobarbital | 1979 |
Influence of the hypoxic cell sensitizer misonidazole on the proliferation of well-oxygenated cells in vitro during prolonged exposure.
Topics: Animals; Cell Cycle; Cell Division; Cell Line; Hypoxia; Mice; Misonidazole; Mitosis; Nitroimidazoles; Osteosarcoma; Oxygen; Sarcoma, Experimental; Time Factors | 1979 |